Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 58 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Body image distress in women and men with advanced pancreatic cancer approaching death – post-hoc analyses from the MISTRAL-trial
    Charlotte Goodrose-Flores, Stephanie E. Bonn, Linda Björkhem-Bergman +1
    Supportive Care in CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Glucagon-like peptide−1 receptor agonist use and risk of postmastectomy lymphedema in breast cancer survivors: a multicenter real-world cohort study
    Dawit Hailemariam Yesho, Muluken Zeleke Megiso, Chidiebube Ugwu +4
    Supportive Care in CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Is age just a number? Causal modeling of recurrence risk in rectal cancer.
    Thanat Tantinam, Pawit Sutharat, Suwan Sanmee +9
    Annals of coloproctologyPeer-reviewedCC BY-NCFull textOncologyEurope PMCDOAJPMC
  4. Associations between physical activity expectations, health literacy, and life satisfaction in cancer patients: results of a quantitative cross-sectional study.
    Franziska Ostendorf, Emilia Hintze, Luise Schütze +7
    Journal of cancer research and clinical oncologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. Absence of Viable Tumor Cells in Macroscopically Pigmented Regional Lymph Nodes after Immune Checkpoint Inhibitor Therapy in Duodenal Metastasis of Cutaneous Melanoma: A Case Report.
    Ryota Unno, Yoshihiro Shirai, Yoshimasa Nobeyama +8
    Surgical case reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  6. Synthesis of azo metal complexes for efficient photocatalytic diclofenac degradation: experimental studies and statistical optimization.
    Musa A Said, Ehsan Ullah Mughal, Nafeesa Naeem +6
    RSC advancesPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  7. Hematological Profiles and Serum Cytokine Levels in Patients With Breast Cancer in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis of Current Evidence.
    Richard Vikpebah Duneeh, Otchere Addai-Mensah, Benedict Sackey +8
    Health science reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  8. Dual PD-1/LAG-3 Blockade in Breast Cancer: Navigating Benefit and Risk.
    Kaixiang Feng, Fanxiang Yin, Mengting Chen +1
    Cancer innovationPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  9. Liquid Biopsy: Past, Present, and Future.
    Jiachen Liu, Dianjie Zeng, Keran Zhao +6
    MedCommPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  10. Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis.
    Makoto Mihara, Hisako Hara
    Plastic and reconstructive surgery. Global openPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  11. C19 trityl and silyl andrographolide analogs exhibit in vitro anticancer activity in murine cancer models
    R. Raval, R. Liu, A. Pak +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  12. Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma
    Bradley T. Stevens, Yang Zhang, Matthew R. Garcia +17
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  13. Implementation and Evaluation of Marker Rescue and qPCR Assays for Detection of Replication-Competent Retrovirus in Gene Therapy Products
    H. Ebrahimiyan, A. Sayadmanesh, H. Baharvand +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  14. Cancer cell adaptations along a proliferation-robustness axis drive TME pro-tumor phenotypes
    Maayan Pour, Guisheng Zhao, Angeliki Karatza +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  15. A CTCF-LDHB axis converts nuclear lactate availability into an H3K18 acylation switch that directs alternative splicing in hypoxic breast cancer
    P. Kakani, A. Brahma, B. Jithin +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  16. Tumour architecture inverts ARNT-dependent growth regulation and reveals CPE-mediated spheroid expansion in luminal breast cancer
    H. OZKAN COSKUN, F. B. BERBER, E. KANSIZ +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  17. Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarcinoma
    Shayan Sarkar, Monisankar Ghosh, Lyanne Delgado-Coka +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  18. Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors to enhance response to immune checkpoint blockade
    M. E. Takashima, Z. Danaceau, M. Bio Idrissou +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  19. Targeted Gene Sequencing for Head and Neck Cancer Candidate Genes in the Nepal case-control study
    Ishor Thapa, Chun-Pin Esther Chang, Angela K Snow +9
    medRxivPreprintCC BYFull textOncologymedRxivPMC
  20. Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India
    A. Ghosh, A. Ghosh, A. Sinha +9
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  21. Residual disease as a therapy-remodeled ecosystem: spatial niches, tumor persistence, and relapse in solid tumors
    Nataša Prvulović Bunović, Olivera Ivanov, Saima Korać +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  22. From discordance to clinical decision support: integrating longitudinal imaging and ctDNA through multimodal artificial intelligence in precision oncology
    Jian Zheng, Luyang Chi, Yong Guo
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  23. Locally manufactured point-of-care CD19 chimeric antigen receptor T-cell therapy for paediatric relapsed/refractory B-cell acute lymphoblastic leukaemia: a single-centre feasibility experience
    Wilson Yau Ki Chan, Alex Wing Kwan Leung, Hui Zhang +11
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  24. C-reactive protein-albumin-lymphocyte index and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis
    Yu Wei, Lingyan Mai, Xiuli Zhang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  25. Dramatic and sustained regression of an inferior vena cava tumor thrombus in a patient with unresectable giant hepatocellular carcinoma following sequential systemic therapy: a case report and literature review
    Ju Hou, Kun Li Wu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref